Paolo Tarantino: Retrospective study by Viale et al. on HER2-low breast cancer.

Quoting Paolo Tarantino, Research Fellow at the Dana-Farber Cancer Institute, on Twitter:

”Just out on ESMO Open a global, retrospective study by Viale et al. on HER2-low (vs 0) breast cancer (n=789). No notable differences in features & outcomes were found between HER2-low vs HER2-0 cases. Upon rescoring, >30% of HER2-0 cases became HER2-low.”

For the article click here.
Source: Paolo Tarantino/Twitter